Commodore Capital’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $96.1M | Hold |
|
|||||
|
2025
Q2 | $94.1M | Buy |
|
|||||
|
2025
Q1 | $92M | Buy |
|
|||||
|
2024
Q4 | $94.6M | Buy |
|
|||||
|
2024
Q3 | $105M | Buy |
|
|||||
|
2024
Q2 | $92.9M | Hold |
|
|||||
|
2024
Q1 | $69.9M | Buy |
|
|||||
|
2023
Q4 | $40.2M | Hold |
|
|||||
|
2023
Q3 | $39.6M | Buy |
|
|||||
|
2023
Q2 | $47.9M | Buy |
|
|||||
|
2023
Q1 | $37.9M | Buy |
|
|||||
|
2022
Q4 | $10.2M | Buy |
|